Search Videos and More
News
A transposase-derived gene required for human brain development
A groundbreaking study published in Science Advances and featuring Phoenix Children’s investigators Michael Kruer, MD and Patricia Cornejo,, MD reveals a previously unknown requirement for somatic genetic diversity among neurons in normal brain development.
News
Phoenix Children’s Designated a GLUT1 Deficiency Collaborative Care Network Site
Phoenix Children’s is officially a GLUT1 Deficiency Collaborative Care Network site, highlighting their expertise in rare neurological care and ketogenic diet therapy i
Symposium
Advancing Pediatric Neuroscience: 2025 Innovation Report
The 2025 Innovation Report showcases a selection of the transformative initiatives undertaken over the past year. From pioneering clinical programs and cutting-edge research to novel therapeutic interventions, our multidisciplinary teams have worked relentlessly to address some of the most complex neurological conditions in pediatric medicine.
Video
Enhancing Precision in Pediatric Neurosurgery: Advanced Robotics Integration with LITT
Phoenix Children’s continues to advance minimally invasive neurosurgical techniques with the integration of advanced robotics into Laser Interstitial Thermal Therapy (LITT) procedures
Video
Spotlight on Neuropsychology: An Integrated Approach to Pediatric Brain Health
Dr. Ashley Whitaker, Board-Certified Pediatric Neuropsychologist and Division Chief of Neuropsychology at Phoenix Children’s, leads a team that plays a vital role in the multidisciplinary care of children with neurological and medical complexities.
Video
First Awake Brain Surgery at Phoenix Children’s
Dr. Jason Hauptman performed Phoenix Children’s first ever Awake Craniotomy. Watch as Dr. Hauptman performs this procedure and discusses how it enables surgeons to operate more precisely and safely.
Symposium
Barrow Neurological Institute at Phoenix Children's 2024 Innovation Report
The 2024 Innovation Report highlights some of the transformative work accomplished over the past year. From groundbreaking clinical programs to cutting-edge research and novel therapeutic approaches, our multidisciplinary teams have worked tirelessly to address some of the most complex neurological disorders in children.
News
Cerebral Vasculopathy in Neurofibromatosis Type 1: An Under-Recognized Problem?
Neurofibromatosis type 1 (NF1) is a common genetic disorder caused by mutations in the NF1 gene, which encodes neurofibromin, a GTPase-activating protein (GAP)-related domain that negatively regulates the Ras/mitogen-activated protein kinase (RAS/MAPK) signaling pathway.
News
Advancing the Care of Children with Cerebrovascular Disease
Pediatric cerebrovascular disease is a significant cause of global morbidity and mortality among children.
News
The Future of Pediatric Epilepsy Surgery Through a Genetic Lens
Epilepsy in children continues to be a large-scale medical issue in children, affecting approximately 4 in 1,000 children each year. Epilepsy is defined as having two unprovoked, nonfebrile seizures.
News
Hypoglossal Nerve Stimulation: A Novel Tool for Treating Obstructive Sleep Apnea in Children
Hypoglossal nerve stimulation is an advanced and emerging therapeutic approach designed to manage obstructive sleep apnea (OSA).
News
Phoenix Children’s Names New Chief of Neurosurgery
Phoenix Children’s, one of the nation’s fastest-growing pediatric health systems, today announced the hire of accomplished surgeon-scientist Jason Scott Hauptman, MD, PhD, as division chief of neurosurgery, part of Barrow Neurological Institute at Phoenix Children’s.